Suchergebnisse - "Escribano, Pilar"

PubPharm (18)

1

Clonal spread of fluconazole-resistant C. parapsilosis in patients admitted to a referral hospital located in Burgos, Spain, during the COVID-19 pandemic

enthalten in: Mycoses | 2024

von Mantecón-Vallejo, M. | Mesquida, A. | Ortiz, M. | +8

2

Antifungal resistance in Candida spp within the intra-abdominal cavity : study of resistance acquisition in patients with serial isolates

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2023

von Díaz-García, J. | Machado, M. | Alcalá, L. | +51

3

Yeasts from blood cultures in the wake of the COVID-19 pandemic in a tertiary care hospital : Shift in species epidemiology, steady low antifungal resistance and full in vitro ibrexafungerp activity

enthalten in: Medical mycology | 2023

von Díaz-García, J. | Mesquida, A. | Machado, M. | +4

4

Amphotericin B, itraconazole, posaconazole, and isavuconazole MICs against clinical Mucorales isolates obtained by visual inspection and spectrophotometric reading according to the EUCAST 9.4 procedure

enthalten in: Medical mycology | 2023

von Escribano, P. | Mesquida, A. | López-Montesinos, S. | +3

5

Gradient diffusion strips for detecting azole resistance in Aspergillus fumigatus sensu lato

enthalten in: Mycoses | 2023

von Serrano-Lobo, J. | Gómez, A. | Reigadas, E. | +52

6

EUCAST-Obtained Olorofim MICs against Aspergillus and Scedosporium Species and Lomentospora prolificans Showed High Agreements between Visual Inspection and Spectrophotometric Readings

enthalten in: Antimicrobial agents and chemotherapy | 2022

von Escribano, P. | Gómez, A. | Reigadas, E. | +3

7

In vitro activity of olorofim against Aspergillus fumigatus sensu lato clinical isolates : activity is retained against isolates showing resistance to azoles and/or amphotericin B

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2022

von Escribano, P. | Gómez, A. | Reigadas, E. | +3

8

ΔF659 and F659S substitutions at the HS1 of FKS2 gene, along with E655A and W715L upstream and downstream substitutions, correlate with high ibrexafungerp MICs against Candidaglabrata

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2022

von Mesquida, A. | Díaz-García, J. | Sánchez-Carrillo, C. | +5

9

In vitro activity of ibrexafungerp against Candida species isolated from blood cultures. Determination of wild-type populations using the EUCAST method

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2022

von Mesquida, A. | Díaz-García, J. | Sánchez-Carrillo, C. | +3

10

Spectrophotometric azole and amphotericin B MIC readings against Aspergillus fumigatus sensu lato using the EUCAST 9.3.2 methodology. Are ≥90 and ≥95% fungal growth inhibition endpoints equally suitable?

enthalten in: Medical mycology | 2021

von Serrano-Lobo, J. | Gómez, A. | Muñoz, P. | +2